Aurinia Pharmaceuticals Overview
Aurinia Pharmaceuticals Target Price
Analysts' 12-month price predictions for AUPH.
Get informed when a big investor buys or sells
+ FollowShare Price
$16
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-12-03 | Leerink Partners | $16 |  0% upside |  |
| 2025-11-04 | RBC Capital | $15 |  6.3% downside | |
| 2024-09-06 | H.C. WainwrightEd Arce | $13 | 18.8% downside | |
| 2024-05-02 | JefferiesMaury Raycroft | $6 | 62.5% downside | |
| 2023-01-04 | RBC Capital | $11 | 31.3% downside | |
| 2022-08-09 | H.C. Wainwright | $26 | 62.5% upside | |
| 2022-08-08 | Oppenheimer | $13 | 18.8% downside | |
| 2022-05-05 | H.C. Wainwright | $30 | 87.5% upside | |
| 2022-04-28 | RBC Capital | $22 | 37.5% upside | |